Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
Location status: Recruiting
Location contact
Jennifer R. Brown, MD, PhD
CONTACT
Jennifer R. Brown, MD, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT00131014
The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Boston, Massachusetts, 02115, United States
Location status: Recruiting
Jennifer R. Brown, MD, PhD
CONTACT
Jennifer R. Brown, MD, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Indefinite
Genetic factors that contribute to the development of lymphomas and CLL
Contact information is provided by the study sponsor or research team.
Celeste Carey, MS
CONTACT
Jennifer Brown, MD PhD
CONTACT
Dana-Farber Cancer Institute
Other
Establishing a Tumor Bank and Initial Analysis of Germline and Tumor-Related Genetic Alterations in Families With Multiple Lymphoproliferative Malignancies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01890486
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia
Winston-Salem, North Carolina, United States
View Trial DetailsNCT01555892
Hemic and Lymphatic Diseases, Hodgkin Disease
Houston, Texas, United States
View Trial DetailsNCT01696461
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia
Tampa, Florida, United States
View Trial DetailsNCT00975975
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia
Indianapolis, Indiana, United States
View Trial Details